These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 17353448)

  • 1. Positive pretransplantation cytomegalovirus serology is a risk factor for cardiac allograft vasculopathy in children.
    Hussain T; Burch M; Fenton MJ; Whitmore PM; Rees P; Elliott M; Aurora P
    Circulation; 2007 Apr; 115(13):1798-805. PubMed ID: 17353448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytomegalovirus infection and cardiac allograft vasculopathy in children.
    Webber SA
    Circulation; 2007 Apr; 115(13):1701-2. PubMed ID: 17404170
    [No Abstract]   [Full Text] [Related]  

  • 3. CMV mismatch does not affect patient and graft survival in UK renal transplant recipients.
    Johnson RJ; Clatworthy MR; Birch R; Hammad A; Bradley JA
    Transplantation; 2009 Jul; 88(1):77-82. PubMed ID: 19584684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of cytomegalovirus in cardiac allograft vasculopathy.
    Weill D
    Transpl Infect Dis; 2001; 3 Suppl 2():44-8. PubMed ID: 11926750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does cytomegalovirus serology impact outcome after pediatric heart transplantation?
    Mahle WT; Fourshee MT; Naftel DM; Alejos JC; Caldwell RL; Uzark K; Berg A; Kanter KR;
    J Heart Lung Transplant; 2009 Dec; 28(12):1299-305. PubMed ID: 19783178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed-onset primary cytomegalovirus disease after liver transplantation.
    Arthurs SK; Eid AJ; Pedersen RA; Dierkhising RA; Kremers WK; Patel R; Razonable RR
    Liver Transpl; 2007 Dec; 13(12):1703-9. PubMed ID: 18044717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus serostatus pairing and deceased donor kidney transplant outcomes in adult recipients with antiviral prophylaxis.
    Kuo HT; Ye X; Sampaio MS; Reddy P; Bunnapradist S
    Transplantation; 2010 Nov; 90(10):1091-8. PubMed ID: 20885340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effectiveness of preemptive therapy with ganciclovir in recipients of renal transplants at high risk (R-/D+) for the development of cytomegalovirus disease].
    Aranda-Verástegui F; Alberú J; Soto-Ramírez LE; González-Aguirre H; Muñoz Trejo T; Mancilla E; Díliz H; Correa-Rotter R; Sierra-Madero J
    Rev Invest Clin; 2002; 54(3):198-203. PubMed ID: 12183888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does valganciclovir hydrochloride (valcyte) provide effective prophylaxis against cytomegalovirus infection in liver transplant recipients?
    Jain A; Orloff M; Kashyap R; Lansing K; Betts R; Mohanka R; Menegus M; Ryan C; Bozorgzadeh A
    Transplant Proc; 2005 Sep; 37(7):3182-6. PubMed ID: 16213344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cytomegalovirus infection after heart transplantation. Retrospective analysis of an antiviral CMV prevention].
    Antretter H; Höfer D; Klaus A; Larcher C; Margreiter J; Margreiter R
    Dtsch Med Wochenschr; 2000 Apr; 125(15):445-51. PubMed ID: 10800441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of donor-recipient cytomegalovirus serology on adult liver transplantation: a single center experience.
    Tryphonopoulos P; Weppler D; Morris MI; Russo C; Nishida S; Levi DM; Moon J; Tekin A; Selvaggi G; Island E; Arosemena L; Ruiz P; Tzakis AG
    Transplantation; 2011 Nov; 92(9):1051-7. PubMed ID: 21876474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reassessing the impact of cytomegalovirus infection in kidney and kidney-pancreas transplantation.
    Becker BN; Becker YT; Leverson GE; Simmons WD; Sollinger HW; Pirsch JD
    Am J Kidney Dis; 2002 May; 39(5):1088-95. PubMed ID: 11979354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus Infection After Intestinal/Multivisceral Transplantation: A Single-Center Experience With 210 Cases.
    Nagai S; Mangus RS; Anderson E; Ekser B; Kubal CA; Fridell JA; Tector AJ
    Transplantation; 2016 Feb; 100(2):451-60. PubMed ID: 26247555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with the development of cytomegalovirus infection following solid organ transplantation.
    da Cunha-Bang C; Sørensen SS; Iversen M; Sengeløv H; Hillingsø JG; Rasmussen A; Mortensen SA; Fox ZV; Kirkby NS; Christiansen CB; Lundgren JD
    Scand J Infect Dis; 2011 May; 43(5):360-5. PubMed ID: 21306196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical analysis of valganciclovir dosing and renal function on the development of cytomegalovirus infection in kidney transplantation.
    Posadas Salas MA; Taber DJ; Chua E; Pilch N; Chavin K; Thomas B
    Transpl Infect Dis; 2013 Dec; 15(6):551-8. PubMed ID: 24010993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus after heart transplantation. Risk factors for infection and death: a multiinstitutional study. The Cardiac Transplant Research Database Group.
    Kirklin JK; Naftel DC; Levine TB; Bourge RC; Pelletier GB; O'Donnell J; Miller LW; Pritzker MR
    J Heart Lung Transplant; 1994; 13(3):394-404. PubMed ID: 8061014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylaxis versus preemptive anti-cytomegalovirus approach for prevention of allograft vasculopathy in heart transplant recipients.
    Potena L; Grigioni F; Magnani G; Lazzarotto T; Musuraca AC; Ortolani P; Coccolo F; Fallani F; Russo A; Branzi A
    J Heart Lung Transplant; 2009 May; 28(5):461-7. PubMed ID: 19416774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features and outcomes of delayed-onset primary cytomegalovirus disease in cardiac transplant recipients.
    Kijpittayarit-Arthurs S; Eid AJ; Kremers WK; Pedersen RA; Dierkhising RA; Patel R; Razonable RR
    J Heart Lung Transplant; 2007 Oct; 26(10):1019-24. PubMed ID: 17919622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Impact of initial cytomegalovirus viral load on efficacy of preemptive therapy with ganciclovir in allogeneic stem cell transplant recipients].
    Torre-Cisneros J; Caston-Osorio JJ; Martín C; Rivero A; Doblas A; Rojas R; Gómez P; Martínez F; Torres A
    Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):6-12. PubMed ID: 19409666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis: a post hoc analysis of a randomized, placebo-controlled study.
    Valantine HA; Gao SZ; Menon SG; Renlund DG; Hunt SA; Oyer P; Stinson EB; Brown BW; Merigan TC; Schroeder JS
    Circulation; 1999 Jul; 100(1):61-6. PubMed ID: 10393682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.